Immunology

Immunology is the study of the body's immune system.

What is Immunology?

Immunology is the branch of biomedical science that deals with the response of an organism to antigenic challenge and its recognition of what is self and what is not. It deals with the defence mechanisms including all physical, chemical and biological properties of the organism that help it to combat its susceptibility to foreign organisms, material, etc.

Classical Immunology

Improving Transplantation Outcomes in Positive Crossmatch Kidney Transplantation

Cells of the Adaptive Immune System

Immunology: A Very British History

What are PARP inhibitors?

B Cell Development

Mannan-binding Lectin Serine Protease (MASP) Family

Developmental Immunology

What is Neuroimmunology?

Evolutionary Immunology

Cells of the Innate Immune System

See more featured articles »

The Immunological Functions of Red Blood Cells

What does it mean to be Immunocompromised?

The Different Types of Immunostaining

Clinical Immunology

What are the Types of Neuroinflammation?

Latest Immunology News and Research

Unusual allergy triggers cause anaphylaxis in children and teenagers

When people think about anaphylaxis, peanuts, shellfish, or even bee sting often come to mind. Three medically challenging cases presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Scientific Meeting show that severe allergic reactions can come from far less obvious places: a fish ingredient hidden in an energy drink, a natural hair oil and a popular children's sensory toy.

12 Nov 2026

Clinicians continue ordering food allergy panels despite false positive risks

New research being presented at the 2026 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) showed many clinicians in a survey knew that food allergy panel testing often results in false positives- yet they kept ordering it anyway.

12 Nov 2026

Experimental vaccines aim to treat and prevent aggressive cancers

For more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer.

12 Nov 2026

Biologic drug offers promising protection against alpha-gal syndrome

The summer of 2026 was a particularly bad season for ticks. And with it came a rising number of cases of alpha-gal syndrome (AGS) thanks to bites from the Lone Star Tick.

12 Nov 2026

Stocking epinephrine in schools protects students and eases family financial burdens

For school kids with severe food allergies, having epinephrine on hand at school can mean the difference between a scary moment and a life-threatening one.

12 Nov 2026

Language barriers delay early peanut introduction for many infants

Feeding peanut products to infants early in life is one of the best tools doctors have to help prevent peanut allergy.

12 Nov 2026

Study reveals frequent insurance denials for pediatric biologic allergy treatments

When a child's severe asthma, eczema, hives, or food allergy isn't under control, an allergist may prescribe a newer type of medicine called a biologic.

12 Nov 2026

Biologic drug for eosinophilic esophagitis lowers childhood asthma risk

Young children treated for eosinophilic esophagitis (EoE) with dupilumab (a biologic medication) were less likely to develop asthma in the future compared with children who received a different treatment.

12 Nov 2026

New method reveals how individual glioblastoma cells spread through the brain

By combining live imaging of brain tissue with artificial intelligence, researchers at Uppsala University have developed a method that reveals how individual glioblastoma cells spread through the brain, how they can switch between different ways of moving, and how they are affected by cancer treatments. An

12 Nov 2026

$7.2 million NIH funding supports research into long-lived plasma cells

Central to many immune responses are antibodies, which identify foreign substances and help remove them from the body. The immune cells that produce them are called plasma cells, and they can mature into long-lived plasma cells that persist and provide protection for years or even decades.

11 Nov 2026

Targeting brain cleaning gene could help treat or prevent Alzheimer's

A gene responsible for compacting trash inside the brain appears to be a key player in Alzheimer's disease, and doctors may be able to target it to better treat or help prevent the devastating condition, new UVA Health research suggests.

10 Nov 2026

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund.

6 Nov 2026

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), in a poster session at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, December 12-15, 2026.

5 Nov 2026

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

A review led by Professor Weidong Zhang at the School of Pharmacy, Naval Medical University, was published in Volume 2 of the journal Immunity & Inflammation on October 27, 2026. The article systematically examines the translational bottlenecks and potential solutions for plant-derived anti-inflammatory compounds.

5 Nov 2026

Medical societies unify to endorse evidence-based respiratory vaccine guidance

Hoping to provide much-needed guidance to clinicians treating patients with lung disease and to promote respiratory health, the Vaccine Guidance Review Panel, a multi-medical society effort, announced its endorsement of influenza, RSV and COVID-19 recommendations for adults and children.

5 Nov 2026

Engineered IL-39 cytokine unlocks new pathways for immunotherapy

In a new preclinical study, scientists present a molecular engineering approach to modify and repurpose a cytokine named IL-39, which plays a central role in inflammation and immunity.

5 Nov 2026

Supervised food challenges clear many infants of suspected peanut allergy

A world-first national program has discovered more than a third of babies thought to have a peanut allergy could safely have the diagnosis removed. And the findings are changing how Australia's healthcare system approaches infant food allergies.

4 Nov 2026

Protein DUSP4 prevents immune cell exhaustion in colorectal cancer

The immune system has powerful cells that can recognize and destroy cancer, but this ability can gradually wane when the cells reside within a tumor.

4 Nov 2026

Researchers develop method to generate billions of cDC1 immune cells

Conventional type 1 dendritic cells, known as cDC1 cells, are immune cells that help initiate responses against intracellular pathogens and tumors.

4 Nov 2026

AlphaFold3 reveals molecular interactions driving T cell recognition

Researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, have developed a new approach using the artificial intelligence platform AlphaFold3 to predict whether a T cell receptor will recognize a specific antigen based solely on its genetic sequence.

3 Nov 2026